Literature DB >> 15794942

Involvement of uracil nucleotides in protection of cardiomyocytes from hypoxic stress.

Smadar Yitzhaki1, Vladimir Shneyvays, Kenneth A Jacobson, Asher Shainberg.   

Abstract

Cardiomyocytes express one or more subtypes of P2 receptors for extracellular nucleotides. P2 purinoceptors, which are activated by nucleotides, are classified as P2X or P2Y: P2X receptors are ligand-gated intrinsic ion channels, and P2Y receptors are G protein-coupled receptors. Extracellular pyrimidine and purine nucleotides are released from the heart during hypoxia. Although the cardioprotective effects of purines acting via purinoceptors were studied intensively, the physiological role of uracil nucleotide-responsive P2Y2, P2Y4, P2Y6, and P2Y14 receptors is still unclear, especially in the cardiovascular system. This study revealed that uridine-5'-triphosphate (UTP) protected cultured rat cardiomyocytes during hypoxia and explored the UTP signaling pathway leading to this cardioprotection. We found that UTP, but not UDP or uridine, significantly reduced cardiomyocyte death induced by hypoxia. Incubation with UTP for 1 h, before exposure to hypoxic conditions, protected the cells 24 h later. The cardioprotective effect of UTP was reduced in the presence of the P2 antagonist suramin. In addition, UTP caused a transient increase of [Ca2+]i in cardiomyocytes. Pyridoxal-5'-phosphate-6-azophenyl-2,4-disulfonate (PPADS) or Reactive blue 2 (RB-2), other antagonists of P2 receptors, abolished the [Ca2+]i elevation caused by UTP. We used various inhibitors of the Ca2+ signaling pathway to show that UTP elevated levels of [Ca2+]i, originating from intracellular sources, via activation of phospholipase C and the IP3 receptor. Interestingly, these inhibitors of the Ca2+ signaling pathway did not prevent the immediate protective effect caused by UTP. Although mitochondrial KATP channels are involved in other preconditioning mediator pathways, the involvement of these channels in the cardioprotective effect induced by UTP was ruled out, because 5-hydroxydecanoic acid (5-HD), a specific inhibitor of these channels, did not prevent the protection.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15794942      PMCID: PMC3449160          DOI: 10.1016/j.bcp.2005.01.018

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  36 in total

Review 1.  Purinergic and pyrimidinergic receptors as potential drug targets.

Authors:  M Williams; M F Jarvis
Journal:  Biochem Pharmacol       Date:  2000-05-15       Impact factor: 5.858

Review 2.  Adenosine 5'-triphosphate: a P2-purinergic agonist in the myocardium.

Authors:  G Vassort
Journal:  Physiol Rev       Date:  2001-04       Impact factor: 37.312

3.  Activation of A(3)adenosine receptor protects against doxorubicin-induced cardiotoxicity.

Authors:  V Shneyvays; L Mamedova; T Zinman; K Jacobson; A Shainberg
Journal:  J Mol Cell Cardiol       Date:  2001-06       Impact factor: 5.000

4.  Inositol 1,4,5-trisphosphate directs Ca(2+) flow between mitochondria and the Endoplasmic/Sarcoplasmic reticulum: a role in regulating cardiac autonomic Ca(2+) spiking.

Authors:  M Jaconi; C Bony; S M Richards; A Terzic; S Arnaudeau; G Vassort; M Pucéat
Journal:  Mol Biol Cell       Date:  2000-05       Impact factor: 4.138

5.  Cardioprotective effects of adenosine A1 and A3 receptor activation during hypoxia in isolated rat cardiac myocytes.

Authors:  N Safran; V Shneyvays; N Balas; K A Jacobson; H Nawrath; A Shainberg
Journal:  Mol Cell Biochem       Date:  2001-01       Impact factor: 3.396

6.  Evidence for selective coupling of alpha 1-adrenergic receptors to phospholipase C-beta 1 in rat neonatal cardiomyocytes.

Authors:  J F Arthur; S J Matkovich; C J Mitchell; T J Biden; E A Woodcock
Journal:  J Biol Chem       Date:  2001-08-06       Impact factor: 5.157

Review 7.  Molecular pharmacology of P2Y-receptors.

Authors:  I von Kügelgen; A Wetter
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2000-11       Impact factor: 3.000

Review 8.  Advances in signalling by extracellular nucleotides. the role and transduction mechanisms of P2Y receptors.

Authors:  D Communi; R Janssens; N Suarez-Huerta; B Robaye; J M Boeynaems
Journal:  Cell Signal       Date:  2000-06       Impact factor: 4.315

9.  Enhanced IPC by activation of pertussis toxin-sensitive and -insensitive G protein-coupled purinoceptors.

Authors:  Hideki Ninomiya; Hajime Otani; Kejie Lu; Takamichi Uchiyama; Masakuni Kido; Hiroji Imamura
Journal:  Am J Physiol Heart Circ Physiol       Date:  2002-05       Impact factor: 4.733

10.  A specific role of phosphatidylinositol 3-kinase gamma. A regulation of autonomic Ca(2)+ oscillations in cardiac cells.

Authors:  C Bony; S Roche; U Shuichi; T Sasaki; M A Crackower; J Penninger; H Mano; M Pucéat
Journal:  J Cell Biol       Date:  2001-02-19       Impact factor: 10.539

View more
  18 in total

1.  Involvement of UTP in protection of cardiomyocytes from hypoxic stress.

Authors:  Asher Shainberg; Smadar Yitzhaki; Or Golan; Kenneth A Jacobson; Edith Hochhauser
Journal:  Can J Physiol Pharmacol       Date:  2009-04       Impact factor: 2.273

2.  Invited Lectures : Overviews Purinergic signalling: past, present and future.

Authors: 
Journal:  Purinergic Signal       Date:  2006-05-15       Impact factor: 3.765

Review 3.  Cardiac purinergic signalling in health and disease.

Authors:  Geoffrey Burnstock; Amir Pelleg
Journal:  Purinergic Signal       Date:  2014-12-20       Impact factor: 3.765

4.  The purinergic G protein-coupled receptor 6 inhibits effector T cell activation in allergic pulmonary inflammation.

Authors:  Giorgio Giannattasio; Shin Ohta; Joshua R Boyce; Wei Xing; Barbara Balestrieri; Joshua A Boyce
Journal:  J Immunol       Date:  2011-07-01       Impact factor: 5.422

Review 5.  Agonists and antagonists for P2 receptors.

Authors:  Kenneth A Jacobson; Stefano Costanzi; Bhalchandra V Joshi; Pedro Besada; Dae Hong Shin; Hyojin Ko; Andrei A Ivanov; Liaman Mamedova
Journal:  Novartis Found Symp       Date:  2006

6.  Uridine-5'-triphosphate (UTP) reduces infarct size and improves rat heart function after myocardial infarct.

Authors:  Smadar Yitzhaki; Asher Shainberg; Yelena Cheporko; Bernardo A Vidne; Alex Sagie; Kenneth A Jacobson; Edith Hochhauser
Journal:  Biochem Pharmacol       Date:  2006-08-30       Impact factor: 5.858

7.  Adenosine A(1) and A (3) receptor agonists reduce hypoxic injury through the involvement of P38 MAPK.

Authors:  D Leshem-Lev; E Hochhauser; B Chanyshev; A Isak; A Shainberg
Journal:  Mol Cell Biochem       Date:  2010-08-22       Impact factor: 3.396

8.  Loss of Mouse P2Y6 Nucleotide Receptor Is Associated with Physiological Macrocardia and Amplified Pathological Cardiac Hypertrophy.

Authors:  Sophie Clouet; Larissa Di Pietrantonio; Evangelos-Panagiotis Daskalopoulos; Hrag Esfahani; Michael Horckmans; Marion Vanorlé; Anne Lemaire; Jean-Luc Balligand; Christophe Beauloye; Jean-Marie Boeynaems; Didier Communi
Journal:  J Biol Chem       Date:  2016-05-26       Impact factor: 5.157

9.  Autophagy induced by ischemic preconditioning is essential for cardioprotection.

Authors:  Chengqun Huang; Smadar Yitzhaki; Cynthia N Perry; Wayne Liu; Zoltan Giricz; Robert M Mentzer; Roberta A Gottlieb
Journal:  J Cardiovasc Transl Res       Date:  2010-05-11       Impact factor: 4.132

10.  Positive inotropic effects by uridine triphosphate (UTP) and uridine diphosphate (UDP) via P2Y2 and P2Y6 receptors on cardiomyocytes and release of UTP in man during myocardial infarction.

Authors:  Anna-Karin Wihlborg; Johanna Balogh; Lingwei Wang; Catharina Borna; Ying Dou; Bhalchandra V Joshi; Eduardo Lazarowski; Kenneth A Jacobson; Anders Arner; David Erlinge
Journal:  Circ Res       Date:  2006-03-16       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.